Right insights.
Right channels.
Every relevant stakeholder.

Our omnichannel medical communications make oncology and hematology clinical innovations relevant and impactful for healthcare professionals, payers, and patients.

TRM Oncology

A medical communications agency, by the numbers

We have some of the brightest minds in oncology and hematology medical communications. Our global resources, strategic programs, and longstanding relationships with key scientific leaders provide our life science partners with future-focused, evidence-based solutions – all designed to improve clinical decision making and enhance patient outcomes. View our Facts & Figures Infographic.

Education Icon

55+

Team members with unmatched expertise

Research Icon

15+

Therapeutic areas supported

Bottle Icon

2/3

Of all new oncology drugs supported in the last 3 years

Global Reach Icon

550+

Worldwide projects completed annually

Are you ready to explore new ideas?

Learn the many ways TRM Oncology can support you and your valued stakeholders.

All fields required

The power of evidence-based, omnichannel innovation

D3

Helping our partners successfully navigate the complex oncology and hematology marketplace is a critical part of what we do best. That’s why we created D3 – our unique, 3-phase approach provides competitive solutions to your most difficult challenges, every time.

1We Discover the insights that will have the greatest impact on the relevant stakeholders in your market

2We Develop creative, customized solutions that precisely target each insight and stakeholder

3We Deliver each insight to the right stakeholder through the right mix of relevant channels

We partner with the world’s best

AstraZeneca

Bayer

Lilly

Merck

Merck KGAa

Novartis

Roche

Pfizer

TRM icon

Up-to-date stories, articles, and insights from the TRM Oncology team

February 21st, 2018
Trends in HCP Segmentation and Targeting

Over the years, healthcare providers (HCPs) have changed and expanded the ways in which they communicate. How the pharma industry practices HCP segmentation should now reflect a more value-based approach. This means segmentation should be based not only on how valuable HCPs are to the pharma company (a traditional approach), but also by how the […]

Read more
February 14th, 2018
Emerging Disruptions: Pharma Marketing Trends You Can’t Ignore

There are several emerging disruptions that, as a pharma marketer, you can’t afford to ignore. These trends are artificial intelligence (which includes machine learning and email automation), personalization as an approach to marketing, digital therapeutic apps and sensors, and telehealth and remote care.

Read more
February 7th, 2018
Allowing HCPs to Drive the Pharma Marketing Conversation

Typically, a pharma marketing strategy is carefully devised, by collecting relevant research data and garnering an understanding of the current market space. It used to be that the marketing message was meant to assume the needs of physicians, and spoke to how the product or service benefited those needs.

Read more

Want to learn more about TRM Oncology? We’d love to talk with you.

Contact Us